HDAC9 and breast carcinoma: Furthermore, a highly organized functional crosstalk between LSD1 and HDAC1 has been demonstrated in breast cancer cells, in which silencing of LSD1 expression augmented the tumor suppressive effects of the pan-HDAC inhibitor SAHA [54,55,56].